Edelmann establishes Edelmann Leaflet Solutions

Published: 10-Oct-2011
Packaging Finance

New firm is a merger of two of its operations in Germany

The Edelmann Group, a German folding cartons and leaflet specialist, is bundling its activities in the leaflets business into a new company called Edelmann Leaflet Solutions.

The newly founded company will merge two of the Group’s operations in Germany – Lindauer Druckerei Eschbaumer in Lindau and Wepack in Leverkusen.

The Heidenheim-based Edelmann Group extended its leaflets business in June by installing up-to-date folding machines in its facilities and with an overall annual capacity of 1.5 billion units, it is now one Germany’s largest leaflet manufacturers.

The firm says establishing Edelmann Leaflet Solutions will allow orders to be managed outside the individual facilities in Lindau and Leverkusen. This means that capacities can be increased at short notice and the duration of projects shortened while increasing flexibility.

In total Edelmann operates 12 sites serving the healthcare and beauty sectors: in Germany (Carl Edelmann, Artur Theis, Braun Pharmadruck, Lindauer Druckerei Eschbaumer, Wesche and Wepack), France (Edelmann France), Poland (Edelmann Poland), Hungary (Zalai Nyomda), Mexico (Edelmann Mexico) and China (Edelmann Beijing) and employs around 1,500 people.

In 2010, the Group generated revenue of €188m. Worldwide it produced 4.2 billion items of folding cartons and leaflets.

See more

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Read more
Novel solution developed by Schreiner MediPharm and Edelmann

Trending Articles

  1. AecorBio raises $1.5m at $30m valuation to advance investigational studies of its novel prostate cancer peptide FT-002a The financing will support preparations for a 2026 FDA Investigational New Drug (IND) application, paving the way for clinical development of the co-therapy designed to restore iron metabolism and boost treatment response
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Cloud labelling and serialisation: the new frontline of traceability in drug delivery As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
  3. Simris Biologics secures €200K funding to develop microcystin-based payloads for antibody-drug conjugates The Berlin-based subsidiary will use the grant to advance the KlicMic R&D programme, creating targeted microcystin payloads for ADCs that aim to improve cancer therapy efficacy whilst reducing side effects
  4. Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    From approval to access: the strategic role of packaging in drug launch success In today’s increasingly complex pharmaceutical landscape, securing regulatory approval is only one milestone on the journey to market

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Packaging

The future of the package insert: the on-pack booklet-label

Novel solution developed by Schreiner MediPharm and Edelmann
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Packaging firms develop smarter options

While serialisation is top of most agendas, the development of Cloud-based services and smart phone solutions also offer new marketing opportunities. Susan Birks reports
Packaging

Edelmann wins Pharmapack Award for vial packaging

Third award won by folding carton concept
Packaging

Edelmann leads development of standard for tamper-evident closures

European working group will publish initial draft this year
Packaging

Edelmann increases label production capacity

Invests in folding machines at three plants
Finance

Bio Protocol raises $6.9m to launch AI-powered decentralised science platform

The new platform enables researchers and patients to create "BioAgents" — autonomous AI co-scientists — to bring a faster, blockchain-verified path from lab to market
Finance

AecorBio raises $1.5m at $30m valuation to advance investigational studies of its novel prostate cancer peptide FT-002a

The financing will support preparations for a 2026 FDA Investigational New Drug (IND) application, paving the way for clinical development of the co-therapy designed to restore iron metabolism and boost treatment response
Subscribe now